Search Results

There are 4770 results for: content related to: Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation

  1. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Version of Record online : 6 OCT 2005, DOI: 10.1002/mds.20724

  2. Pergolide for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    C E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000235

  3. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 858–866, William Koller, Andrew Lees, Miroslava Doder, Mariese Hely and the Tolcapone/Pergolide Study Group

    Version of Record online : 20 SEP 2001, DOI: 10.1002/mds.1175

  4. You have free access to this content
    Cost-Effectiveness of Pergolide Compared to Bromocriptine in the Treatment of Parkinson's Disease: A Decision-Analytic Model

    Value in Health

    Volume 4, Issue 4, July 2001, Pages: 308–315, Peter Davey, Narayan Rajan, Michael Lees and Michael Aristides

    Version of Record online : 28 JUN 2008, DOI: 10.1046/j.1524-4733.2001.44039.x

  5. Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000236

  6. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  7. Pergolide Mesylate for Cocaine Abuse: A Controlled Preliminary Trial

    The American Journal on Addictions

    Volume 8, Issue 2, Spring 1999, Pages: 120–127, Frances R. Levin, David McDowell, Suzette M. Evans, Daniel Brooks, Christina Spano and Edward V. Nunes

    Version of Record online : 18 FEB 2010, DOI: 10.1080/105504999305929

  8. You have free access to this content
    Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum

    Journal of Neurochemistry

    Volume 102, Issue 3, August 2007, Pages: 699–711, Evgeny Bychkov, M. Rafiuddin Ahmed, Kevin N. Dalby and Eugenia V. Gurevich

    Version of Record online : 21 MAR 2007, DOI: 10.1111/j.1471-4159.2007.04586.x

  9. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists

    European Journal of Neurology

    Volume 14, Issue 6, June 2007, Pages: 644–649, A. LLedó, M. A. Dellva, I. M. Strombom, J. L. Wilkie, Mark E. Jungemann, M. G. Royer, V. E. Simmons and P. A. Cavazzoni

    Version of Record online : 29 MAY 2007, DOI: 10.1111/j.1468-1331.2007.01801.x

  10. Diagnosis and management of pergolide-induced fibrosis

    Movement Disorders

    Volume 19, Issue 6, June 2004, Pages: 699–704, Pinky Agarwal, Stanley Fahn and Steven J. Frucht

    Version of Record online : 19 MAY 2004, DOI: 10.1002/mds.20200

  11. Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses

    Veterinary Dermatology

    Volume 24, Issue 1, February 2013, Pages: 212–e47, Marie Innerå, Annette D. Petersen, Danielle R. Desjardins, Barbara A. Steficek, Edmund J. Rosser Jr and Harold C. Schott II

    Version of Record online : 19 JAN 2013, DOI: 10.1111/j.1365-3164.2012.01080.x

  12. Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor

    Movement Disorders

    Volume 18, Issue 11, November 2003, Pages: 1324–1331, Prithiva Navan, Leslie J. Findley, Jim A.R. Jeffs, Ronald K.B. Pearce and Peter G. Bain

    Version of Record online : 12 AUG 2003, DOI: 10.1002/mds.10538

  13. A review of the efficacy of the dopamine agonists pergolide and bromocriptine in the treatment of Parkinson's disease

    European Journal of Neurology

    Volume 4, Issue 6, November 1997, Pages: 537–543, V. Nohria and A. Partiot

    Version of Record online : 20 JAN 2011, DOI: 10.1111/j.1468-1331.1997.tb00403.x

  14. You have free access to this content
    High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities

    Journal of Mass Spectrometry

    Volume 38, Issue 7, July 2003, Pages: 743–751, Nicola Hughes, Witold Winnik, Jean-Jacques Dunyach, Ma'an Amad, Maurizio Splendore and Gary Paul

    Version of Record online : 15 JUL 2003, DOI: 10.1002/jms.489

  15. Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study

    Movement Disorders

    Volume 21, Issue 8, August 2006, Pages: 1109–1113, Cecilia Peralta, Elisabeth Wolf, Hannes Alber, Klaus Seppi, Silvana Müller, Sylvia Bösch, Gregor K. Wenning, Otmar Pachinger and Werner Poewe

    Version of Record online : 18 APR 2006, DOI: 10.1002/mds.20887

  16. Pergolide Mesylate: Adverse Events Occurring in the Treatment of Cocaine Dependence

    The American Journal on Addictions

    Volume 6, Issue 2, Spring 1997, Pages: 117–123, Robert Malcolm, Juliann W. Moore, Daniel K. Kajdasz and Carolyn E. Cochrane

    Version of Record online : 18 FEB 2010, DOI: 10.1111/j.1521-0391.1997.tb00560.x

  17. A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide

    European Journal of Neurology

    Volume 12, Issue 1, January 2005, Pages: 1–8, P. Navan, L. J. Findley, M. B. Undy, R. K. B. Pearce and P. G. Bain

    Version of Record online : 21 DEC 2004, DOI: 10.1111/j.1468-1331.2004.01019.x

  18. Physiologic disposition of pergolide

    Clinical Pharmacology & Therapeutics

    Volume 30, Issue 2, August 1981, Pages: 258–265, Alan Rubin, Louis Lemberger and Patricia Dhahir

    Version of Record online : 25 AUG 1981, DOI: 10.1038/clpt.1981.157

  19. Science-in-brief: Report from the Second European Equine Endocrinology Symposium

    Equine Veterinary Journal

    Volume 46, Issue 5, September 2014, Pages: 525–528, A. E. Durham, R. J. Geor, J. L. Ireland, C. M. McGowan and H. C. Schott

    Version of Record online : 7 AUG 2014, DOI: 10.1111/evj.12313

    Corrected by:

    ERRATUM: Erratum

    Vol. 46, Issue 6, 778, Version of Record online: 15 OCT 2014

  20. You have free access to this content
    Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2267–2302, Claudia Trenkwalder, Wayne A. Hening, Pasquale Montagna, Wolfgang H. Oertel, Richard P. Allen, Arthur S. Walters, Joao Costa, Karin Stiasny-Kolster and Cristina Sampaio

    Version of Record online : 16 OCT 2008, DOI: 10.1002/mds.22254